Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nicholls

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Environmental Management|March 23, 2013
A new river system modelling tool for sustainable operational management of water resourcesDushmanta Dutta, Kym Wilson, Wendy D Welsh, et al.
IEEE Transactions on Bio-Medical Engineering|March 6, 2012
Synchrony dynamics across brain structures in limbic epilepsy vary between initiation and termination phases of seizuresTiwalade Sobayo, Ananda S Fine, Elizabeth Gunnar, et al.
International Journal of Technology Assessment in Health Care|June 24, 2026
ASSESSING COST EFFECTIVENESS IN ONCOLOGY TREATMENT SEQUENCES: A REVIEW OF PATHWAY MODELLING METHODS FOR HEALTH TECHNOLOGY ASSESSMENTLucy Beggs, Kusal Lokuge, Ayman Sadek, et al.
Clinical Rheumatology|April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
Rheumatology and Therapy|February 27, 2023
Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial DataVivian P Bykerk, Peter Nash, David Nicholls, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 10, 2009
Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancersDaria Yu Alakhova, Nataliya Y Rapoport, Elena V Batrakova, et al.
Qualitative Health Research|September 19, 2025
Staying With the Trouble, a Rhizomatic Approach to Posthuman Methods: Assemblages and Becoming in the Posthuman Walking ProjectClair Hebron, Shirley Chubb, David Nicholls, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
Evaluation of a series of bicyclic CXCR2 antagonistsIain Walters, Caroline Austin, Rupert Austin, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonistsLilian Alcaraz, Andrew Bailey, Elaine Cadogan, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2015
Discovery and evaluation of a novel monocyclic series of CXCR2 antagonistsRupert P Austin, Colin Bennion, Roger V Bonnert, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Environmental Management|March 23, 2013
A new river system modelling tool for sustainable operational management of water resourcesDushmanta Dutta, Kym Wilson, Wendy D Welsh, et al.
IEEE Transactions on Bio-Medical Engineering|March 6, 2012
Synchrony dynamics across brain structures in limbic epilepsy vary between initiation and termination phases of seizuresTiwalade Sobayo, Ananda S Fine, Elizabeth Gunnar, et al.
International Journal of Technology Assessment in Health Care|June 24, 2026
ASSESSING COST EFFECTIVENESS IN ONCOLOGY TREATMENT SEQUENCES: A REVIEW OF PATHWAY MODELLING METHODS FOR HEALTH TECHNOLOGY ASSESSMENTLucy Beggs, Kusal Lokuge, Ayman Sadek, et al.
Clinical Rheumatology|April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
Rheumatology and Therapy|February 27, 2023
Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial DataVivian P Bykerk, Peter Nash, David Nicholls, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 10, 2009
Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancersDaria Yu Alakhova, Nataliya Y Rapoport, Elena V Batrakova, et al.
Qualitative Health Research|September 19, 2025
Staying With the Trouble, a Rhizomatic Approach to Posthuman Methods: Assemblages and Becoming in the Posthuman Walking ProjectClair Hebron, Shirley Chubb, David Nicholls, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
Evaluation of a series of bicyclic CXCR2 antagonistsIain Walters, Caroline Austin, Rupert Austin, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonistsLilian Alcaraz, Andrew Bailey, Elaine Cadogan, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2015
Discovery and evaluation of a novel monocyclic series of CXCR2 antagonistsRupert P Austin, Colin Bennion, Roger V Bonnert, et al.
Pageof 3